日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement

探索治疗驱动的预后三重生物标志物的亚克隆演变:KMT2A重排急性髓系白血病患者新亚型中的双基因融合和嵌合RNA变体

Yi Xu ,Shengwen Calvin Li ,Jeffrey Xiao ,Qian Liu ,Durga Cherukuri ,Yan Liu ,Saied Mirshahidi ,Jane Xu ,Xuelian Chen ,Dadrastoussi Homa ,Julian Olea ,Kaijin Wu ,Kevin R Kelly ,Fengzhu Sun ,Ruihao Huang ,Xiaoqi Wang ,Qin Wen ,Xi Zhang ,Cristina M Ghiuzeli ,Esther Chong ,Hisham Abdel-Azim ,Mark E Reeves ,David J Baylink ,Huynh Cao ,Jiang F Zhong

Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

维奈克拉和伊达沙努特林在复发/难治性 AML 中的应用:一项非随机、开放标签 1b 期试验

Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee, Kevin R Kelly, Norbert Vey, Sarit Assouline, Gail J Roboz, Stefania Paolini, Daniel A Pollyea, Agostino Tafuri, Joseph M Brandwein, Arnaud Pigneux, Bayard L Powell, Pierre Fenaux, Rebecca L Olin, Giuseppe Visani, Giovann

Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial

全面的单细胞免疫分析确定了 Ib 期试验中溶瘤病毒治疗后患者的多发性骨髓瘤微环境

Steffan T Nawrocki #, Julian Olea #, Claudia Villa Celi, Homa Dadrastoussi, Kaijin Wu, Denice Tsao-Wei, Anthony Colombo, Matt Coffey, Eduardo Fernandez Hernandez, Xuelian Chen, Gerard J Nuovo, Jennifer S Carew, Ann F Mohrbacher, Paul Fields, Peter Kuhn, Imran Siddiqi, Akil Merchant, Kevin R Kelly

Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography-tandem mass spectrometry

液相色谱-串联质谱法定量测定人血浆和脑组织中的纳替马德林

Amanda B Kagan, Nicole M Anders, Avelina Hemingway, Eudocia Q Lee, Kevin R Kelly, Hans C Lee, Meng Xu-Welliver, Richard Piekarz, Michelle A Rudek

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus

连接粘附分子-A 在晚期多发性骨髓瘤中过度表达,并决定对溶瘤呼肠孤病毒的反应

Kevin R Kelly, Claudia M Espitia, Weiguo Zhao, Erik Wendlandt, Guido Tricot, Fenghuang Zhan, Jennifer S Carew, Steffan T Nawrocki

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib

新型 Aurora A 激酶抑制剂 MLN8237 对耐药性慢性粒细胞白血病有效,并显著提高尼洛替尼的疗效

Kevin R Kelly, Jeffrey Ecsedy, Ernest Medina, Devalingam Mahalingam, Swaminathan Padmanabhan, Steffan T Nawrocki, Francis J Giles, Jennifer S Carew

Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis

硫蒽酮是一种新型自噬抑制剂,可诱导蛋白酶 D 介导的细胞凋亡

Jennifer S Carew, Claudia M Espitia, Juan A Esquivel 2nd, Devalingam Mahalingam, Kevin R Kelly, Guru Reddy, Francis J Giles, Steffan T Nawrocki